DSM’s latest Global Insight Series report says the main reason consumers purchase lactose-free dairy products in emerging markets such as Colombia and China is the health appeal of the products, not merely lactose-intolerance.
DSM’s lactose-free dairy ingredient Maxilact has been granted a European patent - giving the company exclusive permission to market "clean taste" arylsulfatase-free lactase enzymes in the region until 2026.